CURE Pharmaceutical Readies $12 Million U.S. IPO

CURE Pharmaceutical has proposed terms for its IPO. The firm is developing and commercializing … the Philippines, Taiwan, Vietnam, and Thailand, with clinical trials planned for 2019.
( read original story …)

---